Literature DB >> 15101892

Methadone in the treatment of chronic nonmalignant pain: a 2-year follow-up.

W F Taylor1, A G Finkel, K R Robertson, A C Anderson, T C Toomey, S A Abashian, J D Mann.   

Abstract

OBJECTIVE: To examine the longitudinal use of methadone in a pain clinic.
DESIGN: Follow-up study of 40 patients initially treated with methadone and re-evaluated 2 years later, comparing those maintained on methadone with those who were switched to other opioids.
SETTING: Pain clinic at a university hospital.
RESULTS: The 14 patients (35%) who stayed on methadone for the duration of the study, had higher employment rates (P <.05) and higher functional ratings (P <.02) than those on other opioids. Side effects were the most common reason (33.4%) for discontinuation of methadone. Dose escalation occurred in 11 of 14 patients (78.6%).
CONCLUSIONS: Chronic pain patients may be safely and effectively treated with methadone. Those not responding or tolerating methadone may be benefited by treatment with other opioids.

Entities:  

Year:  2000        PMID: 15101892     DOI: 10.1046/j.1526-4637.2000.00027.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  4 in total

1.  Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities.

Authors:  Taha Ahmad; Samie Sabet; Donald A Primerano; Lauren L Richards-Waugh; Gary O Rankin
Journal:  J Anal Toxicol       Date:  2017-05-01       Impact factor: 3.367

2.  (R)-methadone versus racemic methadone: what is best for patient care?

Authors:  Elinore F McCance-Katz
Journal:  Addiction       Date:  2011-04       Impact factor: 6.526

Review 3.  Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics.

Authors:  Taha Ahmad; Monica A Valentovic; Gary O Rankin
Journal:  Biochem Pharmacol       Date:  2018-02-16       Impact factor: 5.858

4.  Perspectives of pain specialists, patients, and family members on long-term opioid use for chronic non-cancer pain: a qualitative study.

Authors:  Rattaphol Seangrung; Thongchai Tempeetikul; Supasit Pannarunothai; Supalak Sakdanuwatwong
Journal:  BMC Anesthesiol       Date:  2021-11-09       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.